EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Receptor interacting protein kinase‐3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy

Maximilien Bencze iD, Baptiste Periou, Isabel Punzón, Inès Barthélémy, Valentina Taglietti, Cyrielle Hou, Louai Zaidan, Kaouthar Kefi, Stéphane Blot, Onnik Agbulut, Marianne Gervais, Geneviève Derumeaux und 3 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2023

DOI: 10.1002/jcsm.13265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2023. Verfasst von Maximilien Bencze und 14 weiteren Autor:innen. Beteiligte Einrichtung: Team Relaix, Biology of the Neuromuscular System, U955-IMRB, Inserm, UPEC, ENVA, EFS, Créteil, France. Hauptthemen laut MEDLINE: Cardiomyopathies, Muscular Dystrophy, Duchenne, Receptor-Interacting Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Association Française contre les Myopathies (AFM-Téléthon), French Muscular Dystrophy Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Duchenne muscular dystrophy (DMD) is a progressive muscle degenerative disorder, culminating in a complete loss of ambulation, hypertrophic cardiomyopathy and a fatal cardiorespiratory failure. Necroptosis is the form of necrosis that is dependent upon the receptor‐interacting protein kinase (RIPK) 3; it is involved in several inflammatory and neurodegenerative conditions. We previously identified RIPK3 as a key player in the acute myonecrosis affecting the hindlimb muscles of the mdx dystrophic mouse model. Whether necroptosis also mediates respiratory and heart disorders in DMD is currently unknown.

Methods

Evidence of activation of the necroptotic axis was examined in dystrophic tissues from Golden retriever muscular dystrophy (GRMD) dogs and R‐DMDdel52 rats. A functional assessment of the involvement of necroptosis in dystrophic animals was performed on mdx mice that were genetically depleted for RIPK3. Dystrophic mice aged from 12 to 18 months were analysed by histology and molecular biology to compare the phenotype of muscles from mdx Ripk3 +/+ and mdx Ripk3 −/− mice. Heart function was also examined by echocardiography in 40‐week‐old mice.

Results

RIPK3 expression in sartorius and biceps femoris muscles from GRMD dogs positively correlated to myonecrosis levels ( r = 0.81; P = 0.0076). RIPK3 was also found elevated in the diaphragm ( P ≤ 0.05). In the slow‐progressing heart phenotype of GRMD dogs, the phosphorylated form of RIPK1 at the Serine 161 site was dramatically increased in cardiomyocytes. A similar p‐RIPK1 upregulation characterized the cardiomyocytes of the severe DMDdel52 rat model, associated with a marked overexpression of Ripk1 ( P = 0.007) and Ripk3 ( P = 0.008), indicating primed activation of the necroptotic pathway in the dystrophic heart. Mdx Ripk3 −/− mice displayed decreased compensatory hypertrophy of the heart ( P = 0.014), and echocardiography showed a 19% increase in the relative wall thickness ( P < 0.05) and 29% reduction in the left ventricle mass ( P = 0.0144). Besides, mdx Ripk3 −/− mice presented no evidence of a regenerative default or sarcopenia in skeletal muscles, moreover around 50% less affected by fibrosis ( P < 0.05).

Conclusions

Our data highlight molecular and histological evidence that the necroptotic pathway is activated in degenerative tissues from dystrophic animal models, including the diaphragm and the heart. We also provide the genetic proof of concept that selective inhibition of necroptosis in dystrophic condition improves both histological features of muscles and cardiac function, suggesting that prevention of necroptosis is susceptible to providing multiorgan beneficial effects for DMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesMuscular Dystrophy, DuchenneReceptor-Interacting Protein Serine-Threonine KinasesAnimalsDogsMiceRatsDisease Models, AnimalMice, Inbred mdxProtein Kinases

Stichwörter der Autor:innen

Animal modelCardiac failureDuchenne muscular dystrophyFibrosisMyogenesisMyonecrosisNecroptosisProgrammed cell death

Substanzen

Protein KinasesRipk3 protein, mouseReceptor-Interacting Protein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Team Relaix, Biology of the Neuromuscular System, U955-IMRB, Inserm, UPEC, ENVA, EFS, Créteil, France.
  • Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, Sorbonne Université, Paris, France.
  • Team Derumeaux, Department of Physiology, Henri Mondor Hospital, FHU-SENEC, AP-HP, U955-IMRB, Université Paris-Est Créteil (UPEC), Créteil, France.

ORCID-Profile: Maximilien Bencze

Förderung

  • Association Française contre les Myopathies (AFM-Téléthon)
  • French Muscular Dystrophy Association

Zitieren

APA

Bencze, M., Periou, B., Punzón, I., Barthélémy, I., Taglietti, V., Hou, C., Zaidan, L., Kefi, K., Blot, S., Agbulut, O., Gervais, M., Derumeaux, G., Authier, F. J., Tiret, L., & Relaix, F. (2023). Receptor interacting protein kinase‐3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13265

Vancouver

Bencze M, Periou B, Punzón I, Barthélémy I, Taglietti V, Hou C, et al. Receptor interacting protein kinase‐3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy. Journal of Cachexia, Sarcopenia and Muscle. 2023. doi:10.1002/jcsm.13265

BibTeX
@article{Bencze2023,
  author = {Bencze, Maximilien and Periou, Baptiste and Punzón, Isabel and Barthélémy, Inès and Taglietti, Valentina and Hou, Cyrielle and Zaidan, Louai and Kefi, Kaouthar and Blot, Stéphane and Agbulut, Onnik and Gervais, Marianne and Derumeaux, Geneviève and Authier, François-Jérôme and Tiret, Laurent and Relaix, Fréderic},
  title = {Receptor interacting protein kinase‐3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2023},
  doi = {10.1002/jcsm.13265}
}
Kostenlos starten →